Encompass Health ROA 2010-2024 | EHC

Current and historical return on assets (ROA) values for Encompass Health (EHC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Encompass Health ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $0.42B $6.46B 6.72%
2024-06-30 $0.40B $6.39B 6.48%
2024-03-31 $0.38B $6.23B 6.24%
2023-12-31 $0.35B $6.10B 5.95%
2023-09-30 $0.35B $5.96B 6.08%
2023-06-30 $0.31B $5.86B 5.51%
2023-03-31 $0.27B $5.75B 4.53%
2022-12-31 $0.27B $5.64B 4.31%
2022-09-30 $0.27B $5.48B 4.16%
2022-06-30 $0.33B $7.08B 4.77%
2022-03-31 $0.39B $6.94B 5.79%
2021-12-31 $0.41B $6.87B 6.16%
2021-09-30 $0.41B $6.72B 6.17%
2021-06-30 $0.38B $6.61B 5.86%
2021-03-31 $0.31B $6.54B 4.67%
2020-12-31 $0.29B $6.45B 4.44%
2020-09-30 $0.27B $6.61B 4.22%
2020-06-30 $0.29B $6.50B 4.56%
2020-03-31 $0.34B $6.14B 5.62%
2019-12-31 $0.36B $6.08B 6.00%
2019-09-30 $0.32B $6.39B 5.54%
2019-06-30 $0.31B $5.81B 5.71%
2019-03-31 $0.31B $5.58B 5.93%
2018-12-31 $0.29B $5.18B 5.76%
2018-09-30 $0.34B $5.13B 6.79%
2018-06-30 $0.32B $5.09B 6.41%
2018-03-31 $0.29B $4.94B 5.90%
2017-12-31 $0.27B $4.87B 5.62%
2017-09-30 $0.26B $4.88B 5.46%
2017-06-30 $0.26B $4.84B 5.45%
2017-03-31 $0.26B $4.70B 5.51%
2016-12-31 $0.25B $4.68B 5.35%
2016-09-30 $0.23B $4.63B 4.98%
2016-06-30 $0.22B $4.63B 4.84%
2016-03-31 $0.20B $4.61B 4.70%
2015-12-31 $0.18B $4.61B 4.58%
2015-09-30 $0.18B $4.25B 4.79%
2015-06-30 $0.17B $3.47B 5.26%
2015-03-31 $0.21B $3.58B 6.91%
2014-12-31 $0.22B $3.39B 7.68%
2014-09-30 $0.15B $2.79B 5.71%
2014-06-30 $0.15B $2.58B 6.00%
2014-03-31 $0.23B $2.54B 9.07%
2013-12-31 $0.23B $2.53B 9.24%
2013-09-30 $0.30B $2.56B 12.14%
2013-06-30 $0.29B $2.51B 11.77%
2013-03-31 $0.17B $2.39B 7.05%
2012-12-31 $0.16B $2.42B 6.74%
2012-09-30 $0.16B $2.46B 6.94%
2012-06-30 $0.17B $2.32B 7.52%
2012-03-31 $0.15B $2.30B 6.38%
2011-12-31 $0.18B $2.27B 7.79%
2011-09-30 $0.91B $2.27B 38.40%
2011-06-30 $0.89B $2.38B 39.26%
2011-03-31 $0.91B $2.48B 43.40%
2010-12-31 $0.87B $2.37B 45.70%
2010-09-30 $0.13B $1.80B 7.60%
2010-06-30 $0.12B $1.76B 6.77%
2010-03-31 $0.06B $1.72B 3.64%
2009-12-31 $0.07B $1.68B 3.75%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $9.453B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00